BioNTech Appoints James Ryan as CLO
Experienced pharma exec joins the business’ management board.
BioNTech has appointed James Ryan, PhD, to the management board as chief legal officer (CLO), effective Sept. 1. He will continue to lead the company’s corporate legal strategy and global legal operations, including transactions, corporate governance, securities, intellectual property (IP), insurance, data privacy, among others. Prior to his appointment to the board, James Ryan served as the company’s general counsel and SVP, Legal & IP.
He has nearly 20 years of global legal and IP expertise in the pharma industry. He joined BioNTech in July 2018. Since then, he has guided the company through various key business, IP, and transactional activities.
“We are looking forward to welcoming James Ryan to the management board. Since joining BioNTech in 2018, he has been a trusted advisor and a proven senior leader, given his extensive global experience across key healthcare legal and compliance domains,” comments Helmut Jeggle, Chairman of the BioNTech supervisory board. “ … He combines scientific and legal expertise in an extraordinary manner, contributing to BioNTech’s continued success and growth trajectory. We also value James for his contributions to strengthen BioNTech’s unique culture and his commitment to continue to do so in the future.”
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.
